PCR-based HIV monitor released outside US:
This article was originally published in Clinica
Roche Molecular Systems has released for sale outside the US an automated version of its PCR-based test for monitoring HIV levels in infected patients. The Cobas Amplicor HIV-1 Monitor test (version 1.5), which the company claims is the first to automate the amplification and detection steps of the PCR process, will improve the accuracy and reliability of results, said the Pleasanton, California-based company. When used with the company's UltraSensitive method, the test can measure levels of HIV RNA down to as few as 50 copies/mL of plasma.
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”